Schedule 13D ownership disclosure

AKARI THERAPEUTICS PLC

Security class unavailable · CUSIP: 00972G207

Event date: 2024-01-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
26.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-001229
Form type
SC 13D/A
Filer
Akari Therapeutics Plc
CIK
CIK 1541157
Filed
Jan 04, 2024
Reporting period
Jan 01, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub